BIOMAT Database Logo BIOMAT Database Logo

[Use of glucocorticoids in patients with acute odontogenic inflammatory diseases of the maxillofacial area]. 1977

A V Vasil'ev, and L V Tinteris, and N K Zueva

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010518 Periodontitis Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology) Pericementitis,Pericementitides,Periodontitides
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A V Vasil'ev, and L V Tinteris, and N K Zueva
[Serum phosphatase activity in odontogenic inflammatory diseases of the maxillofacial area].
January 1978, Stomatologiia,
A V Vasil'ev, and L V Tinteris, and N K Zueva
[Bacterial microflora in acute suppurative odontogenic diseases of the maxillofacial area].
January 1985, Stomatologiia,
A V Vasil'ev, and L V Tinteris, and N K Zueva
[Nonsporulating anaerobic microorganisms in acute odontogenic suppurative diseases of the maxillofacial area].
January 1982, Stomatologiia,
A V Vasil'ev, and L V Tinteris, and N K Zueva
[Characteristics of the clinical course of odontogenic inflammatory diseases of the maxillofacial area].
January 1978, Stomatologiia,
A V Vasil'ev, and L V Tinteris, and N K Zueva
[Odontogenic inflammatory diseases of the maxillofacial region].
April 1978, Voenno-meditsinskii zhurnal,
A V Vasil'ev, and L V Tinteris, and N K Zueva
[Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
January 1985, Stomatologiia,
A V Vasil'ev, and L V Tinteris, and N K Zueva
[Mediastinitis--a severe complication of acute odontogenic inflammatory processes of the maxillofacial area].
January 1996, Stomatologiia,
A V Vasil'ev, and L V Tinteris, and N K Zueva
[Defensins level in patients with inflammatory diseases of maxillofacial area].
January 2014, Stomatologiia,
A V Vasil'ev, and L V Tinteris, and N K Zueva
[Differences in the immune status of patients with chronic odontogenic inflammatory processes of the maxillofacial area].
January 1986, Stomatologiia,
A V Vasil'ev, and L V Tinteris, and N K Zueva
[Use of miramistin for the treatment of patients with odontogenic phlegmons in the maxillofacial area].
January 2006, Stomatologiia,
Copied contents to your clipboard!